| Date Filed | Type | Description |
| 01/28/2021 |
GN
| INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Arrowhead Pharmaceuticals, Inc. for Potential Breach of Fiduciary Duty Claims |
| 12/02/2020 |
GN
| NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer |
| 03/18/2020 |
GN
| Bragar Eagel & Squire is Investigating Certain Officers and Directors of comScore, Mammoth Energy, AMC Entertainment, and Arrowhead Pharmaceuticals and Encourages Investors to Contact the Firm |
| 03/10/2020 |
GN
| Bragar Eagel & Squire is Investigating Certain Officers and Directors of comScore, Zuora, AMC Entertainment, and Arrowhead Pharmaceuticals and Encourages Investors to Contact the Firm |
| 02/13/2020 |
GN
| Bragar Eagel & Squire is Investigating Certain Officers and Directors of Zuora, Arrowhead Pharmaceuticals, ResMed, and Covetrus and Encourages Investors to Contact the Firm |
| 03/27/2019 |
GN
| Research Report Identifies Criteo S.A, Ferrari N.V, Freshpet, ServiceMaster Global, CSG Systems International, and Arrowhead Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
| 08/28/2018 |
GN
| New Research Coverage Highlights MACOM Technology Solutions, Arrowhead Pharmaceuticals, PTC Therapeutics, Boot Barn, Darling Ingredients, and Endologix — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 06/26/2018 |
GN
| Investor Expectations to Drive Momentum within AMC Entertainment, Arrowhead Pharmaceuticals, U.S. Silica, Catalent, RSP Permian, and KapStone Paper and Packaging — Discovering Underlying Factors of Influence |
| 05/08/2018 |
BW
| Arrowhead Pharmaceuticals Reports Fiscal 2018 Second Quarter Results |
| 04/24/2018 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Second Quarter Results |
| 03/07/2018 |
GN
| Detailed Research: Economic Perspectives on Etsy, Tiffany, First BanCorp, Deere, Callaway Golf, and Arrowhead Pharmaceuticals — What Drives Growth in Today's Competitive Landscape |
| 03/06/2018 |
BW
| Arrowhead to Present at Barclays Global Healthcare Conference 2018 |
| 02/09/2018 |
BW
| Arrowhead Pharmaceuticals Reports Fiscal 2018 First Quarter Results |
| 02/02/2018 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2018 First Quarter Results |
| 12/12/2017 |
BW
| Arrowhead Pharmaceuticals Reports Fiscal 2017 Year End Results |
| 12/05/2017 |
BW
| Arrowhead Pharmaceuticals to Webcast 2017 Fiscal Year End Results |
| 11/14/2017 |
BW
| Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference |
| 11/13/2017 |
GN
| Analysis: Positioning to Benefit within Catabasis, Flowserve, MGIC Investment, Arrowhead, Silver Spring, and Live Nation – Research Highlights Growth, Revenue, and Consolidated Results |
| 09/14/2017 |
BW
| Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM™ Platform and Lead RNAi-based Drug Candidates |
| 09/01/2017 |
BW
| Arrowhead Pharmaceuticals to Host R&D Day on RNAi-Based Therapies |
| 08/03/2017 |
BW
| Arrowhead Reports Fiscal 2017 Third Quarter Results |
| 07/27/2017 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Third Quarter Results |
| 05/03/2017 |
BW
| Arrowhead Reports Fiscal 2017 Second Quarter Results |
| 04/26/2017 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results |
| 02/06/2017 |
BW
| Arrowhead Reports Fiscal 2017 First Quarter Results |
| 01/30/2017 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results |
| 06/09/2011 |
BW
| Arrowhead Receives Additional 180 Day Grace Period to Comply with the NASDAQ $1.00 Minimum Bid Requirement |
| 05/12/2011 |
BW
| Arrowhead Reports Fiscal 2011 Second Quarter Financial Results |
| 05/04/2011 |
BW
| Arrowhead Research to Report Fiscal 2011 Second Quarter Financial Results and Host Conference Call on Thursday, May 12, 2011 |
| 05/03/2011 |
BW
| Arrowhead Research to Present at the 2011 MDB Capital Group Bright Lights Conference on May 10 |
| 04/27/2011 |
BW
| Arrowhead Research Announces RNAi Leader John J. Rossi, Ph.D. to Join Calando Scientific Advisory Board |
| 04/06/2011 |
BW
| Arrowhead Research Increases Ownership in Ablaris to 64% |
| 03/08/2011 |
BW
| Arrowhead Research to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference on March 16 |
| 02/10/2011 |
BW
| Arrowhead Reports Fiscal 2011 First Quarter Financial Results |
|